Across the broad spectrum of basic scientific and biomedical research conducted by the National Institute of Mental Health (NIMH), Division of Intramural Research Programs (DIRP), the NIMH Technology Transfer Office is responsible for implementing the Federal Technology Transfer Act of 1986 (FTTA), as amended, and Executive Order No. 12591. At the heart of its activities is a deep and continuing commitment to further the Institute's tradition of scientific excellence as NIMH enters the 21st century. Accordingly, the Office carefully monitors, evaluates, and manages the Institute's invention portfolio. Beginning with rigorous review of Employee Invention Reports (EIRs), Office staff negotiate transactional agreements between NIMH and outside parties, including other Federal laboratories, State and local governments, universities, and pharmaceutical and biotechnology companies. :
Among these agreements are Material Transfer Agreements (MTAs) for the exchange of research materials, Cooperative Research and Developments Agreements (CRADAs) for collaborative research endeavors, Clinical Trial Agreements (CTAs) for the conduct of preclinical and clinical studies in human subjects, and Confidential Disclosure Agreements (CDAs) for the exchange of confidential information. The Office also pursues the execution of license agreements. Lastly, Office staff participate in scientific review meetings, discussions, and conferences, as appropriate, to best serve the needs of NIMH scientists. For more information on technology transfer opportunities at NIMH, please visit our information resources below.
The Office of Technology Transfer provides management of the technology transfer activities for the Institute, including the patenting of inventions and negotiating Cooperative Research and Development Agreements (CRADAs), Material Transfer Agreements (MTAs), Confidential Disclosure Agreement (CDAs), and other agreements.
|
